SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Andrew H who wrote (24281)8/9/1998 1:09:00 PM
From: Henry Niman  Respond to of 32384
 
ONTAK is administered via IV and I suspect that there are some costs associated with administering and monitoring, but I suspect that the margins in those areas are rather large also. There is no FDA approved treatment for CTCL, so I would think that the insurance would cover 40K (I'm sure that they would cover $0K)